SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-17-000819
Filing Date
2017-10-20
Accepted
2017-10-20 16:16:05
Documents
3
Group Members
ORBIMED CAPITAL GP V LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss64099_sc13d.htm SC 13D 132950
2 JOINT FILING AGREEMENT ss64099_ex9901.htm EX-99.1 10405
3 LOCK-UP AGREEMENT ss64099_ex9902.htm EX-99.2 18308
  Complete submission text file 0000947871-17-000819.txt   163328
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Subject) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90134 | Film No.: 171147179
SIC: 2834 Pharmaceutical Preparations